TransThera Sciences (Nanjing), Inc. clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-05
What changed in the last 30 days
| First posted | New trial filing | Phase | Status |
|---|---|---|---|
| 2026-10-13 | NCT07871110 Safety, Efficacy and Pharmacokinetics of TT00420 Tablets Combined With Novel Endocrine… | Phase 2 | Recruiting |
Active trials by phase
| Phase 1 | 1 | |
| Phase 2 | 4 | |
| Phase 3 | 2 |
Disease areas by active trials
Cholangiocarcinoma (3) · Breast Cancer (1) · Mantle Cell Lymphoma (1) · Non-Hodgkin Lymphoma (1) · Prostate Cancer (1)
Get alerts when TransThera Sciences (Nanjing), Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.